Explore the latest in colorectal cancer, including advances in the diagnosis, management, screening, and prevention of the disease.
This cohort study uses data from the Health Professionals Follow-up Study, Nurses’ Health Study, and Nurses’ Health Study II to develop a dietary score that correlates with gut sulfur–metabolizing bacteria and to examine its association with colorectal cancer risk.
This cross-sectional study examines trends in the incidence of early-onset colorectal cancer among Black and White US residents aged 40 to 49 years.
This prognostic study develops and validates clinical calculators to predict recurrence-free survival and overall survival among patients with locally advanced rectal cancer treated with chemotherapy, radiotherapy, and surgery.
This systematic review summarizes the patient-reported factors associated with older adults’ decisions to continue screening for breast, prostate, colorectal, and cervical cancer.
This cross-sectional study evaluates the representation of racial and ethnic minority groups in breast, prostate, lung, and colorectal cancer studies with a focus on precision medicine objectives.
This cohort study assesses the rates and factors associated with outpatient low-value cancer screenings among nearly 6 million veterans who visited Veterans Health Administration primary clinics.
This cross-sectional study compares the prevalence of breast and colorectal cancer screening adherence and identifies factors associated with screening adherence among women residing in rural vs urban areas.
This cohort study evaluates stage at diagnosis among patients with gastrointestinal cancer in Japan before and during the COVID-19 pandemic.
This cross-sectional study compares current rates of prescription of fluorouracil, folinic acid, oxaliplatin, and irinotecan plus bevacizumab (FOLFOXIRI-B) with rates from 2015 to 2018 and assesses Dutch medical oncologists’ perspectives on treatment with FOLFOXIRI-B.
This economic evaluation analyzes the cost-effectiveness of screening and prevention strategies by genotype among women with Lynch syndrome.
This cohort study assesses the association of local and national COVID-19 restrictions with tumor burden, as measured by total plasma circulating tumor DNA concentration, among patients newly diagnosed with metastatic colorectal cancer.
This cohort study compares the use of colorectal cancer screening tests before and after the availability of the multitarget stool DNA test.
This cohort study examines associations among body composition profiles, inflammatory marker expressions, and 5-year colon cancer outcomes.
This systematic review and meta-analysis evaluates whether use of monetary incentives encourage adults to undergo colorectal cancer screening.
This qualitative study investigates clinician-identified barriers and facilitators to colonoscopy completion among patients in a safety net health care system who receive abnormal fecal immunochemical test (FIT) results.
This cohort study analyzes the association of metastatic disease pattern with response to programmed cell death receptor 1/programmed cell death ligand 1–targeting therapy in patients with treatment-resistant microsatellite stable metastatic colorectal cancer.
This randomized clinical trial compares outcomes of concomitant and sequential administration of bevacizumab in combination with standard oxaliplatin-based regimens in untreated or single line–treated patients with metastatic colorectal cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.